“It is not often we get such a clear result. For those of you who have not been following this debate on the blog may find the earlier posts around this topic useful.”
Multiple Sclerosis Research: Off–label prescribing
16 Dec 2012
Henry V. Off-label prescribing. Legal implications. J Leg Med. 1999 Sep;20(3):365-83. Some excerpts: ….. The FDA has an official policy to provide physicians the ability to prescribe approved drugs for unapproved uses called …
12 Sep 2012
It is not illegal as suggested to prescribe off-label where other licensed drugs are available. It is potentially (the Avastin litigation has not been resolved) ‘illegal’ for NHS trusts to pay for off-licence drugs in those circumstances …
23 Dec 2012
I posted on this topic last week, under the title off-label prescribing. Each country or region has an agency that licenses drugs; in Europe it is the European Medicines Agency (EMA), in the US the Food and Drug Administration …
17 Dec 2012
The cost differential was so striking that one primary care trust authorised the off-label use of bevacizumab rather than pay for the higher priced option, reversing its stance only after the company offered price concessions. … .